Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adenocarcinoma × enzalutamide × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 93 Breast Neoplasms 10 Neoplasm Metastasis 7 Prostatic Neoplasms, Castration-Resistant 6 Triple Negative Breast Neoplasms 5 Pancreatic Neoplasms 3 Castration-resistant Prostate Cancer 3 Urinary Bladder Neoplasms 2 Prostate Cancer Metastatic 2 Prostate Adenocarcinoma 2 Ovarian Neoplasms 2 Neoplasms 2 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 2 Metastatic Castration-Resistant Prostate Cancer 2 Metastatic Castration Resistant Prostate Cancer 2 Castration Resistant Metastatic Prostate Cancer 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Ureteral Diseases 1 Thrombocytosis 1 Stomach Neoplasms 1 Solid Tumor 1 Salivary Cancer 1 Recurrent Endometrial Endometrioid Adenocarcinoma 1 Prostatic Diseases 1 Prostate Carcinoma Metastatic to the Bone 1 Primary Myelofibrosis 1

Interventions

Oxaliplatin 31 Fluorouracil 23 Gemcitabine 19 Leucovorin 18 Docetaxel 18 pembrolizumab 17 Capecitabine 15 Radiotherapy 13 Irinotecan 13 Bevacizumab 11 Cisplatin 10 Nivolumab 8 130-nm albumin-bound paclitaxel 8 Cyclophosphamide 7 Trastuzumab 6 Radiosurgery 6 Paclitaxel 6 Albumin-Bound Paclitaxel 6 S 1 (combination) 5 Metformin 5 Erlotinib Hydrochloride 5 Carboplatin 5 Blood Specimen Collection 5 Taxes 4 Sunitinib 4 Sorafenib 4 Pemetrexed 4 Esophagectomy 4 Chemoradiotherapy 4 Cetuximab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06844383 2025-10-29

TALENT

Prostate Cancer Clinical Trials Consortium

Phase 2 Recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡